Summary
The University of British Columbia (UBC) is an educational and research institute. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its students. UBC offers educational services through programs such a professional programs, English language pathways, joint academic programs, exchange programs, co-operative education, innovative learning initiatives and distance education programs. The university has its research collaborations with peer institutions, government, non-profit and industry partners. It operates in two campuses namely, Vancouver Campus and Okanagan Campus. UBC is headquartered in Vancouver, British Columbia, Canada
The University of British Columbia - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The University of British Columbia, Medical Devices Deals, 2010 to YTD 2016 9
The University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The University of British Columbia, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
TxCell Enters into Research Agreement with University of British Columbia 12
Sirona Biochem Enters into Research Agreement with University of British Columbia 13
Qu Biologics Enters into Research Agreement with University of British Columbia 14
InMed Pharma Enters into Agreement with University of British Columbia 15
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 16
Cangene Enters Into Research Agreement With University Of British Columbia 17
AlCana Extends Co-Development Agreement With UBC And Alnylam 18
CDRD Enters Into Co-Development Agreement With NGDI-UBC 19
Advaxis Enters Into Co-Development Agreement With University of British Columbia 20
The University Of British Columbia Enters Into Joint Venture Agreement With Max Planck Society 21
Advanced Life Sciences Enters Into Co-Development Agreement With The University of British Columbia 22
Licensing Agreements 23
BirchBioMed Enters into Licensing Agreement with University of British Columbia 23
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 24
Cangene Enters Into Licensing Agreement With University of British Columbia 25
Advanced Inhalation Therapies Enters into Licensing Agreement with University of British Columbia 26
Essa Pharma Amends Licensing Agreement with BC Cancer and University of British Columbia 27
The University of British Columbia And CDRD Enter Into Licensing Agreement With Covidien 29
The University of British Columbia - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
The University of British Columbia, Pharmaceuticals & Healthcare, Key Facts 1
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of British Columbia, Deals By Therapy Area, 2010 to YTD 2016 8
The University of British Columbia, Medical Devices Deals, 2010 to YTD 2016 9
The University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
TxCell Enters into Research Agreement with University of British Columbia 12
Sirona Biochem Enters into Research Agreement with University of British Columbia 13
Qu Biologics Enters into Research Agreement with University of British Columbia 14
InMed Pharma Enters into Agreement with University of British Columbia 15
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 16
Cangene Enters Into Research Agreement With University Of British Columbia 17
AlCana Extends Co-Development Agreement With UBC And Alnylam 18
CDRD Enters Into Co-Development Agreement With NGDI-UBC 19
Advaxis Enters Into Co-Development Agreement With University of British Columbia 20
The University Of British Columbia Enters Into Joint Venture Agreement With Max Planck Society 21
Advanced Life Sciences Enters Into Co-Development Agreement With The University of British Columbia 22
BirchBioMed Enters into Licensing Agreement with University of British Columbia 23
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 24
Cangene Enters Into Licensing Agreement With University of British Columbia 25
Advanced Inhalation Therapies Enters into Licensing Agreement with University of British Columbia 26
Essa Pharma Amends Licensing Agreement with BC Cancer and University of British Columbia 27
The University of British Columbia And CDRD Enter Into Licensing Agreement With Covidien 29
The University of British Columbia, Key Competitors 30
The University of British Columbia, Key Employees 31
The University of British Columbia, Other Locations 32
The University of British Columbia, Subsidiaries 32
List of Figures
The University of British Columbia, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of British Columbia, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The University of British Columbia, Medical Devices Deals, 2010 to YTD 2016 9
